Clinical bottom line
Minimally invasive esophagectomy (MIE) is increasingly being adopted as an alternative to open esophagectomy for the treatment of esophageal cancer. Current evidence suggests that MIE may offer benefits in terms of reduced perioperative morbidity and faster recovery times, while maintaining comparable oncological outcomes to open esophagectomy. However, the choice of surgical approach should be individualized based on patient characteristics, tumor stage, and surgical expertise.
What the evidence shows
Recent systematic reviews and meta-analyses have highlighted the potential advantages of MIE over open esophagectomy. A comprehensive meta-analysis by Markar et al. (2018) demonstrated that MIE is associated with reduced postoperative complications, including pulmonary complications, and shorter hospital stays compared to open esophagectomy (PMID: 29522167). Additionally, a randomized controlled trial by Mariette et al. (2019) reported that MIE resulted in similar overall survival and disease-free survival rates as open esophagectomy, while offering improved quality of life postoperatively (PMID: 30970283).
The TIME trial, a landmark study published in 2012, remains a pivotal reference in this field. It found that MIE significantly reduced pulmonary infection rates and improved short-term quality of life compared to open surgery, establishing a foundation for subsequent research (PMID: 22959430).
Caveats and uncertainty
Despite the promising results, there are several caveats and uncertainties associated with MIE. The learning curve for MIE is steep, and outcomes are highly dependent on the surgeon's experience and institutional volume. Studies have shown that high-volume centers tend to report better outcomes with MIE, suggesting that centralization of care may be beneficial (PMID: 31211918).
Moreover, while short-term outcomes appear favorable, long-term oncological outcomes require further validation. The heterogeneity in study designs, patient populations, and surgical techniques across studies also poses challenges in drawing definitive conclusions.
How this may change practice
The adoption of MIE in clinical practice may lead to improved perioperative outcomes and patient satisfaction, particularly in centers with adequate expertise and resources. Surgeons should consider MIE as a viable option for eligible patients, while also weighing individual patient factors and institutional capabilities. Training programs and guidelines may need to evolve to support the safe implementation of MIE.